» Articles » PMID: 37867510

Bariatric Surgery and Calcifediol Treatment, Gordian Knot of Severe-obesity-related Comorbidities Treatment

Abstract

Background: Obesity (OB) is a chronic metabolic disease with important associated comorbidities and mortality. Vitamin D supplementation is frequently administered after bariatric surgery (BS), so as to reduce OB-related complications, maybe including chronic inflammation.

Aim: This study aimed to explore relations between vitamin D metabolites and components of the inflammasome machinery in OB before and after BS and their relations with the improvement of metabolic comorbidities.

Patients And Methods: Epidemiological/clinical/anthropometric/biochemical evaluation was performed in patients with OB at baseline and 6 months after BS. Evaluation of i) vitamin-D metabolites in plasma and ii) components of the inflammasome machinery and inflammatory-associated factors [NOD-like-receptors (NLRs), inflammasome-activation-components, cytokines and inflammation/apoptosis-related components, and cell-cycle and DNA-damage regulators] in peripheral blood mononuclear cells (PBMCs) was performed at baseline and 6 months after BS. Clinical and molecular correlations/associations were analyzed.

Results: Significant correlations between vitamin D metabolites and inflammasome-machinery components were observed at baseline, and these correlations were significantly reduced 6 months after BS in parallel to a decrease in inflammation markers, fat mass, and body weight. Treatment with calcifediol remarkably increased 25OHD levels, despite 24,25(OH)D remained stable after BS. Several inflammasome-machinery components were associated with improvement in metabolic comorbidities, especially hypertension and dyslipidemia.

Conclusion: The beneficial effects of vitamin D on OB-related comorbidities after BS patients are associated with significant changes in the molecular expression of key inflammasome-machinery components. The expression profile of these inflammasome components can be dynamically modulated in PBMCs after BS and vitamin D supplementation, suggesting that this profile could likely serve as a sensor and early predictor of the reversal of OB-related complications after BS.

Citing Articles

Dynamic Evaluation of Vitamin D Metabolism in Post-Bariatric Patients.

Povaliaeva A, Zhukov A, Tomilova A, Bondarenko A, Ovcharov M, Antsupova M J Clin Med. 2024; 13(1).

PMID: 38202014 PMC: 10779498. DOI: 10.3390/jcm13010007.


Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure-A Randomized Clinical Trial.

Herrera-Martinez A, Jimenez C, Lopez Aguilera J, Crespin M, Manzano Garcia G, Galvez Moreno M Nutrients. 2024; 16(1).

PMID: 38201939 PMC: 10781070. DOI: 10.3390/nu16010110.

References
1.
Jones G, Kaufmann M . Diagnostic Aspects of Vitamin D: Clinical Utility of Vitamin D Metabolite Profiling. JBMR Plus. 2021; 5(12):e10581. PMC: 8674775. DOI: 10.1002/jbm4.10581. View

2.
Marantes I, Achenbach S, Atkinson E, Khosla S, Melton 3rd L, Amin S . Is vitamin D a determinant of muscle mass and strength?. J Bone Miner Res. 2011; 26(12):2860-71. PMC: 3248226. DOI: 10.1002/jbmr.510. View

3.
Pludowski P, Holick M, Pilz S, Wagner C, Hollis B, Grant W . Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013; 12(10):976-89. DOI: 10.1016/j.autrev.2013.02.004. View

4.
Rubino F, Schauer P, Kaplan L, Cummings D . Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010; 61:393-411. DOI: 10.1146/annurev.med.051308.105148. View

5.
Toghaw P, Matone A, Lenbury Y, De Gaetano A . Bariatric surgery and T2DM improvement mechanisms: a mathematical model. Theor Biol Med Model. 2012; 9:16. PMC: 3586953. DOI: 10.1186/1742-4682-9-16. View